Latest Bal Pharma stock price

Bal Pharma P/E Ratio

BALPHARMA • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
16.46
Moderate Valuation
Moderate - Fairly valued

Current Valuation Metrics

P/E Ratio 16.46
Current Price ₹74.72
EPS (TTM) ₹4.54
Exchange NSE

Valuation Signal

Signal Fairly Valued
Historical Avg 34.22
Historical Range 11.47 - 64.14
Percentile 25.0%

Sector Context

Sector Average 48.09
Sector Median 27.37
Sector Rank #11 of 140
Sector Percentile 7.9%

Earnings Breakdown (TTM)

TTM EPS ₹4.63
Sept 2025 ₹0.45
Mar 2025 ₹3.40

Key P/E Ratio Insights for Bal Pharma

  • Current PE is 51.9% below historical average
  • Trading at discount to sector average PE of 48.09

View the BALPHARMA equity price for detailed stock performance.

P/E Ratio Historical Trend for Bal Pharma

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2024 20.64 4.87 ₹100.50 NSE Moderate
2023 40.64 2.25 ₹91.45 NSE High
2022 64.14 1.98 ₹127.00 NSE High
2021 11.47 4.9 ₹56.20 NSE Low

Sector P/E Ratio Comparison

Comparing Bal Pharma with other companies in Healthcare sector
Sector Average
48.09
Sector Median
27.37
Lowest P/E
1.1
Highest P/E
754.17
Companies
140
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 1.1 ₹38 Low
Murae Organisor MURAE 3.14 ₹47 Low
Ind Swift Laboratories INDSWFTLAB 4.87 ₹1,186 Low
Amwill Health Care AMWILL 6.5 ₹67 Low
Medicamen Organics MEDIORG 6.94 ₹27 Low
JFL Life Sciences JFLLIFE 7.53 ₹36 Low
Galaxy Medicare GML 7.66 ₹26 Low
Unichem Laboratories UNICHEMLAB 8.42 ₹2,437 Low
Zenith Drugs ZENITHDRUG 9.03 ₹85 Low
Brooks Laboratories BROOKS 9.44 ₹198 Low